Stocksigma LogoStocksigma Logo

Indrayani Biotech Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs)

■ Revenue: 3,771 (+29.6% YoY | -0.2% QoQ) ■ EBITDA: 147 (-32.7% YoY | -33.7% QoQ) ■ EBITDA Margin (%): 3.9 (-360 bps YoY | -197 bps QoQ) ■ PAT: 26.2

Indrayani Biotech Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs)

Indrayani Biotech Ltd · Financial Result · 07 Oct 2026, 11:38 pm

Indrayani Biotech Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs) ■ Revenue: 3,771 (+29.6% YoY | -0.2% QoQ) ■ EBITDA: 147 (-32.7% YoY | -33.7% QoQ) ■ EBITDA Margin (%): 3.9 (-360 bps YoY | -197 bps QoQ) ■ PAT: 26.2 (+156.1% YoY | Loss to Profit QoQ) ■ EPS (INR): 0.06 (+200.0% YoY | Loss to Profit QoQ)

Original exchange filing (PDF)

More announcements from Indrayani Biotech Ltd

All Indrayani Biotech Ltd announcements